Summary List Placement
Don’t hold your breath for a coronavirus vaccine this fall.
That’s the resounding refrain from US public-health officials, including Robert Redfield, director of the Centers for Disease Control and Prevention. At a Senate subcommittee hearing on Wednesday, Redfield said a vaccine won’t be widely available to the American public until the summer or early fall of 2021.
“There will be vaccine that will initially be available sometime between November and December, but very limited supply and will have to be prioritized,” Redfield said Wednesday. “If you’re asking me when is it going to be generally available to the American public so we can begin to take advantage of vaccine to get back to our regular life, I think we’re probably looking at late second quarter, third quarter 2021.”
But a mere hours after that hearing, President Donald Trump said Redfield was “confused” about the timeline.
“I think he made a mistake when he said that. It’s just incorrect information,” Trump said at a Wednesday evening press conference. “I called him and he didn’t tell me that. I think he got the message maybe confused, maybe it was stated incorrectly.”
Trump then reiterated his prior claim that a vaccine may become available as early as October or “a little bit after” — right around the time of the election on November 3.
He added that “the safety has to be 100%,” but said the distribution process would go quickly.
“We’re not looking to say, ‘Gee, in six months we’re going to start giving it to the general public,'” Trump said. “No, we want to go immediately.”
Pressed on an actual timeline, Trump’s new coronavirus adviser Scott Atlas said the vaccine would be available to high-priority people “no later than January.” He anticipated that there would be 700 million doses by end of the first quarter 2021.
What the experts say about a vaccine timeline
Under the most optimistic vaccine timeline, leading drug companies could see promising results from their clinical trials this fall or by the end of the year. Pfizer and Moderna, in particular, could release results from their phase 3 trials in October. The AstraZeneca-Oxford phase 3 trial could also yield results by the end of 2020, even though that trial was paused briefly after a participant had an adverse reaction.
Never miss out on healthcare news. Click here to subscribe to Business Insider’s daily newsletter on pharma, …read more
Source:: Business Insider